New Method for the Combined Treatment Associated Virus Non-Hodgkin;s Lymphoma
Abstract
Key words: non-Hodgkin's lymphoma, the association of viral, p53, bcl-2, new method of treatment
Annotation: Implementation of patients with malignant lymphomas complex molecular genetic, immuno and immunohistochemical studies in patients for the presence of viral load (hepatitis C, HIV, human papilloma virus HPV, varicella-zoster virus, Epstein-Barr virus) and character the expression of tumor markers p53 and bcl-2 as well as the inclusion complex therapeutic antiviral treatment significantly increased the efficiency of the treatment, thus eliminating the phenomenon of drug resistance and suppress viral persistence in tumor cells and increase the duration of disease-free period and overall survival.
Volltext:
PDF (English)Literaturhinweise
Ha SY, Sung J, Ju H, Karube K, Kim SJ, Kim WS, Seto M, Ko YH. Epstein-Barr virus-positive nodal peripheral T cell lymphomas: Clinicopathologic and gene expression profiling study: Pathol Res Pract, 2013, 13 (3); 0344-S0338.
Hoffman AE, Liu R, Fu A, Zheng T, Slack F, Zhu Y. Targetome profiling, pathway analysis and genetic association study implicate miR-202 in lymphomagenesis: Cancer Epidemiol Biomarkers Prev, 2013, 22 (3); 327-336.
Kirk R. Haematological cancer: Hit the lymphoma, JAK: Nat Rev Clin Oncol, 2012, 9 (11); 608-612.
Shiels MS, Engels EA, Linet MS, Clarke CA, Li J, Hall HI, Hartge P, Morton LM. The Epidemic of Non-Hodgkin Lymphoma in the United States: Disentangling the Effect of HIV, 1992-2009: Cancer Epidemiol Biomarkers Prev, 2013, 22 (6); 1069-1078.
Smith N, Tierney R, Wei W, Vockerodt M, Murray PG, Woodman CB, Rowe M. Induction of Interferon-Stimulated Genes on the IL-4 Response Axis by Epstein-Barr Virus Infected Human B Cells; Relevance to Cellular Transformation: PLoS One, 2013, 8 (5); e64868.
Refbacks
- Im Moment gibt es keine Refbacks